Leksell Gamma Knife® Icon™

Expanded clinical scope with hypofractionation

"We can get patients' treatments done with three to five fractions of radiotherapy, as opposed to the alternative of having them treated on a standard linear accelerator, where their course of treatment may be 5-1/2 to 6 weeks."

Dr. Joseph Bovi
Radiation Oncologist
Froedtert & The Medical College of Wisconsin



Hear more from our users

 Leksell Gamma Knife® Icon™

Elekta Unity

The MOMENTUM Study

In February 2009, the MR-Linac Consortium announced the launch of the MOMENTUM study, which is designed to generate data that enable a safe, fast and, above all, evidence-based introduction of MR/RT into clinical practice.

Prof. Helena Verkooijen, MD, PhD, Professor of Evaluation of Innovation at University Medical Center Utrecht and PI of the MOMENTUM study, details her views on the study and the patient experience with Elekta Unity. Watch the video to learn more.



Learn more

Elekta Unity

MOSAIQ® Oncology Analytics

The oncology business intelligence platform

  • Find efficiencies and potential quality improvements
  • Monitor care patterns and operational trends across your network
  • Detect areas for reducing cost while managing and measuring resource utilization
  • Empower every action and improve patient care


Learn more

Photo

Join us at ASTRO 2019

Don't miss Elekta-hosted events in Chicago

Attending ASTRO? We are offering several excellent opportunities to experience in-depth presentations and demonstrations on hardware and software innovations that are fueling Precision Radiation Medicine. 

  • Hear from experts from across the globe at our User Meeting
  • Explore Elekta's vision for using AI to standarize cancer care globally at our Evening Event
  • Pre-schedule personalized demonstrations on our ASTRO, ASRT and SROA booths


Find out more

Photo

Elekta Assurance

New levels of automation and integration for advanced QA

Quality assurance is a vital part of any radiotherapy service. As treatment technology and complexity have developed, so has the burden of QA — in terms of both time and cost.

How can Elekta Assurance help?

  • Flexible and scalable solutions can shape to fit every customer and offer any QA at any time, for any clinic
  • Centralized and accessible data can effortlessly maintain compliance, reducing time spent on administration
  • Automated workflows can reduce test time up to 90% — so that experts can focus on results rather than tests
  • Innovative real-time and end-to-end QA can bring enhanced confidence and efficiency to any treatment


Explore Elekta Assurance

Elekta Assurance

Leksell® Vantage™ Stereotactic System

Advancing stereotactic neurosurgery

For seventy years, Leksell Stereotactic System has helped clinicians achieve outstanding patient treatment outcomes. Now, with Vantage, clinics can be equipped with better imaging, effective workflows, and patient comfort.



Learn more about Vantage

Leksell® Vantage™ Stereotactic System

FOCUS | Elekta’s Online Magazine


News 1

August 30, 2019

New Swiss interdisciplinary cancer hospital to begin treating patients in December

The cancer treatment facilities of Hôpital Riviera (Vevey, Switzerland), in addition to those of five other regional hospitals, are consolidating into a new interdisciplinary cancer care center, Service Interdisciplinaire de Cancérologie (SIC), which is nearing completion in Rennaz. Hôpital Riviera...

 
News 1

August 5, 2019

Second clinical study on Elekta MR-Linac adds to evidence base for MR-guided radiotherapy

Clinicians at Odense University Hospital (OUH) used their Elekta Unity magnetic resonance radiation therapy (MR/RT) to treat 19 patients, they assessed the critical operational parameters of MR-guided radiotherapy, including patient compliance, workflow efficiency, treatment times and dosimetric accuracy. They reported...

 
News 1

June 25, 2019

New study to learn from every cancer patient treated with MR/RT

The international MR-linac Consortium has launched the MOMENTUM study, the next step in the development of the Elekta Unity MR/RT system. The study is designed to generate data that enable safe, fast and, above all, ‘evidence-based' introduction of magnetic resonance...

 

More stories